Royalty Pharma (RPRX) Earnings Date, Estimates & Call Transcripts → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free RPRX Stock Alerts $28.41 -0.35 (-1.22%) (As of 05/3/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 9Before Market OpensConfirmedActual EPS (Feb. 15) $1.15 Beat By $0.12 Consensus EPS (Feb. 15) $1.03 Get Royalty Pharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for RPRX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRPRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RPRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Priority GoldBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. Royalty Pharma Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$3.95 EPSNext Year EPS Consensus Estimate: $4.32 EPSRPRX Earnings Date and InformationRoyalty Pharma last released its earnings results on February 15th, 2024. The biopharmaceutical company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.03 by $0.12. The business had revenue of $736 million for the quarter, compared to the consensus estimate of $702.90 million. Royalty Pharma has generated $1.89 earnings per share over the last year ($1.89 diluted earnings per share) and currently has a price-to-earnings ratio of 15.0. Earnings for Royalty Pharma are expected to grow by 9.37% in the coming year, from $3.95 to $4.32 per share. Royalty Pharma has confirmed that its next quarterly earnings report will be published on Thursday, May 9th, 2024. Royalty Pharma will be holding an earnings conference call on Thursday, May 9th at 8:00 AM Eastern. Interested parties can register for or listen to the call.. Read More Royalty Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Confirmed)------- 2/15/2024Q4 2023$1.03$1.15+$0.12$1.47$702.90 million$736.00 million11/8/2023Q3 2023$0.81$0.79($0.02)$1.46$640.96 million$637.00 million8/8/2023Q2 2023$0.83$0.85+$0.02$1.32$538.52 million$545.00 million5/9/2023Q1 2023$1.32$1.60+$0.28$2.64$914.72 million$1.13 billion2/15/2023Q4 2022$1.56$1.56-$3.87$1.06 billion$1.06 billion11/8/2022Q3 2022$0.71$0.73+$0.02$1.22$578.03 million$597.00 million Get the Latest News and Ratings for RPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Royalty Pharma and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022$0.78$0.79+$0.01$1.08$511.87 million$524.00 million5/5/2022Q1 2022$0.72$0.61($0.11)$1.13$583.77 million$605.00 million2/15/2022Q4 2021$0.79$0.80+$0.01$1.59$543.50 million$543.00 million 11/10/2021Q3 2021$0.69$0.17($0.52)$1.29$568.92 million$587.00 million 8/11/2021Q2 2021$0.70$0.71+$0.01$0.69$474.52 million$475.00 million5/11/2021Q1 2021$0.65$0.67+$0.02$1.23$489.61 million$524.00 million Royalty Pharma Earnings - Frequently Asked Questions When is Royalty Pharma's earnings date? Royalty Pharma has confirmed that its next quarterly earnings data will be published on Thursday, May 9th, 2024. Learn more on RPRX's earnings history. Did Royalty Pharma beat their earnings estimates last quarter? In the previous quarter, Royalty Pharma (NASDAQ:RPRX) reported $1.15 earnings per share (EPS) to beat the analysts' consensus estimate of $1.03 by $0.12. Learn more on analysts' earnings estimate vs. RPRX's actual earnings. How much revenue does Royalty Pharma generate each year? Royalty Pharma (NASDAQ:RPRX) has a recorded annual revenue of $2.36 billion. How much profit does Royalty Pharma generate each year? Royalty Pharma (NASDAQ:RPRX) has a recorded net income of $1.13 billion. RPRX has generated $1.89 earnings per share over the last four quarters. What is Royalty Pharma's price-to-earnings ratio? Royalty Pharma (NASDAQ:RPRX) has a trailing price-to-earnings ratio of 15.03 and a forward price-to-earnings ratio of 7.19. What is Royalty Pharma's EPS forecast for next year? Royalty Pharma's earnings are expected to grow from $3.95 per share to $4.32 per share in the next year, which is a 9.37% increase. More Earnings Resources from MarketBeat Related Companies: CG Earnings Date BEKE Earnings Date SHG Earnings Date BAM Earnings Date L Earnings Date CRBG Earnings Date AER Earnings Date TPG Earnings Date AEG Earnings Date NTRS Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:RPRX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royalty Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
